Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × dostarlimab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 6 Neoplasms 4 Colonic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Neoplasm Metastasis 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1

Interventions

Cyclophosphamide 21 venetoclax 19 pembrolizumab 17 Dexamethasone 17 fludarabine 14 Cytarabine 13 Gemcitabine 10 Azacitidine 9 pomalidomide 8 Rituximab 8 Lenalidomide 8 Carboplatin 8 selinexor 7 glofitamab 7 fludarabine phosphate 7 Cisplatin 7 daratumumab 6 Temozolomide 6 Paclitaxel 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Oxaliplatin 5 Immunotherapy, Adoptive 5 Decitabine 5 ruxolitinib 4 Surgical Procedures, Operative 4 Nivolumab 4 Drug Therapy 4 Cladribine 4 Calcium Dobesilate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05855811 2024-07-15

PREDOSTAR

Centre Leon Berard

Phase 2 Recruiting

Neoplasms, Recurrence, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡